A recent decision by the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom may lead to malignant pleural mesothelioma patients in that country being treated with nintedanib, a promising cancer drug that has not yet been approved for public use. As is true in the United States, the UK offers the possibility…
The post UK Ruling Means that Nintedanib May Begin to be Used for Mesothelioma Treatment appeared first on Mesothelioma.net.
from Mesothelioma.net http://ift.tt/2mlu3DJ
via IFTTT
UK Ruling Means that Nintedanib May Begin to be Used for Mesothelioma Treatment
![UK Ruling Means that Nintedanib May Begin to be Used for Mesothelioma Treatment]()
Reviewed by Unknown
on
January 11, 2018
Rating:
No comments: